3 min read

How PV Technology is Enabling Advancements in the Assessment of Patient Safety

Round out a comprehensive pharmacovigilance strategy with optimized tech.
Learn how new tools and approaches may significantly streamline and simplify workflows.

Pharmacovigilance (PV) activities must be carefully planned from the outset of the drug development process. A comprehensive PV strategy requires a depth of understanding, not only in terms of the complex and rapidly evolving safety landscape but also in new tools and approaches that may significantly streamline and simplify workflows, increase the capacity of your team, lower your cost to deliver safety services and most importantly, helping you differentiate and maximize the value of your products in the marketplace.

Below are a few process automation solutions UBC has implemented within our PV technology operations which we believe offer our clients a best-in-class experience as a provider of comprehensive global pharmacovigilance services:

  • AI-Based Case Intake Automation – We have automated our workflows and leveraged cognitive technologies, such as optical and intelligent character recognition (OCR/ICR) and natural language processing (NLP), combined with our library of safety-specific user interfaces to facilitate rapid case intake and data entry.
  • Electronic Reportable Event Forms (eRefs) – We developed electronic reportable event forms (eREFs) to further streamline the case intake and data entry process. This solution is ideal for a high volume of cases due to web-based data entry forms that replace paper forms.
  • AI-Based Literature Review – Leveraging our DistillerSR platform, we can better focus on the content of the documents under review without separately managing work in disparate spreadsheets. The platform utilizes AI and advanced machine learning algorithms to automatically prioritize documents and call out keywords requiring attention providing error reduction with confidence.

Process innovations are complemented with UBC’s robust reporting platform capabilities, reducing turn-around time for custom-line listings through:

  • Advanced Reporting Solutions – Streamline the process of generating validated and compliant database outputs by removing the need for custom report development and validation.
  • Standard Analytics Dashboards – Access key program analytics through a cloud-based, self-service portal.

Pharmaceutical and biotechnology companies benefit from working with external partners to manage PV activities. The breadth and scope of required services can depend on the mix of investigational and marketed products, the size of the company, and their comfort with outsourcing safety. Organizations realize a variety of benefits when collaborating with an experienced and innovative technology partner for safety services. Contact UBC today to connect with a member of our industry-leading PV Team.

Additional Resources

Are you PV ready? Evaluate your program using our complimentary Safety Readiness Checklist here and ensure the proper oversight is in place for all of your safety reporting.

Other Recent Posts

Press
5 min read

UBC Successfully Implemented REMS Administration Software DuringHL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.
Press
5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences' safety case management solution.
Press
2 min read

UBC Receives CRO Leadership Award Again

UBC was honored as a winner in the 2023 CRO Leadership Awards by both big and small pharma in the Reliability category.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.